Price T Rowe Associates Inc Gossamer Bio, Inc. Transaction History
Price T Rowe Associates Inc
- $883 Billion
- Q2 2025
A detailed history of Price T Rowe Associates Inc transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 95,291 shares of GOSS stock, worth $183,911. This represents 0.0% of its overall portfolio holdings.
Number of Shares
95,291
Previous 64,777
47.11%
Holding current value
$183,911
Previous $72,000
63.89%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding GOSS
# of Institutions
135Shares Held
159MCall Options Held
2.89MPut Options Held
130K-
Octagon Capital Advisors LP New York, NY18.4MShares$35.4 Million8.57% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$34.9 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$22 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$15.5 Million5.25% of portfolio
-
Acadian Asset Management LLC Boston, MA7.15MShares$13.8 Million0.02% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $181M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...